<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Vilnius-Lithuania-OG_InterLab skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Vilnius-Lithuania-OG/InterLab</SPAN></H1></DIV></DIV></DIV><TITLE>Collaborations</TITLE><DIV id="" class="clearfix"><HEADER id="header" class="page-section full-header"><DIV id="header-wrap" style="padding-left:1%"><DIV class="clearfix"><NAV id="primary-menu"><UL><LI id="homeheader"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG">Home</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Overview">Project</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Overview">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Design_Regulatory">Design for Regulatory Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Model">Modelling</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Demonstrate">Proof of Concept</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Measurement">Measurement</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Nucleotide_Design">Substrate Design Prospects</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Entrepreneurship">Entrepreneurship</A></LI></UL><LI id="softwareh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Software">Software</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Software">Motivation</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Gan_Introduction">Generative Adversarial Network – GAN</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/ProteinGAN">Protein GAN</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/ReactionGAN">Reaction GAN</A></LI><LI id="partsh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-basic">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-composite">Composite Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-collection">Collection</A></LI><LI id="notebookh"><A href="/pages/notebook/index.html">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/catseqguide">Using the CAT-Seq</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/labnotebook">Lab Journal</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/InterLab">Interlab</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Safety">Safety</A></LI><LI id="humanh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Human_Practices">Human practices</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Public_Engagement">Education and Public Engagement</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Collaborations">Collaborations</A></LI><LI id="peopleh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/People">People</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/People">Team</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Sponsors">Sponsors</A></LI></NAV></DIV></DIV></HEADER><SECTION id="slider" class="slider-element slider-parallax full-screen force-full-screen with-header swiper_wrapper page-section clearfix"><DIV class="slider-parallax-inner"><DIV class="swiper-container swiper-parent"><DIV class="swiper-wrapper"><DIV class="swiper-slide" style="background-image: url('https://static.igem.org/mediawiki/2018/a/a4/T--Vilnius-Lithuania-OG--interlab-virselis.jpg');"><DIV class="container clearfix"><DIV class="slider-caption slider-caption-center"><H2 data-caption-animate="fadeInUp">Interlab</H2></DIV></DIV></DIV></DIV></DIV></DIV></SECTION><DIV id="page-menu"><DIV id="page-menu-wrap"><DIV class="container clearfix"><DIV class="menu-title">Explore <SPAN>INTERLAB</SPAN></DIV><NAV class="one-page-menu"><UL><LI><A href="#" data-href="#overview">Overview</A></LI><LI><A href="#" data-href="#section-methods">Methods and Results</A></LI><LI><A href="#" data-href="#section-conclusions">Conclusions</A></LI></UL></NAV></DIV></DIV></DIV><SECTION style="overflow:hidden; position:relative; background-color: #FFF;"><DIV class="content-wrap"><DIV class="container clearfix"><DIV class="single-post nobottommargin"><DIV class="entry clearfix"><SECTION id="overview" class="page-section"><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">The
							fifth InterLab study has launched and it further attempts to develop
							a standard procedure for green fluorescent protein (GFP) measurements
							to reduce variability across laboratories in the world. This year the
							attempt is to normalize fluorescence measurements to colony forming
							units (CFU) instead of optical density of the culture since it is a
							great source of variability among labs. Two approaches were used to
							compute the cell number in the samples: </FONT></P><OL style="PADDING-LEFT: 30px"><LI><P style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">Converting
								absorbance of cells to absorbance of known concentration beads;</FONT></P></LI><LI><P style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">Counting
								CFU in the samples. </FONT></P></LI></OL><SECTION id="section-methods" class="page-section"><H2>Methods and Results</H2><DIV class="fancy-title title-border-color"><H4>1. Calibration	protocols</H4></DIV><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">At
							firstly, we measured absorbance (Abs<SUB>600</SUB>)
							of weakly scattering LUDOX CL-X to obtain a multiplication factor of
							Abs<SUB>600</SUB>
							to transform absorbance values to the comparable OD<SUB>600</SUB>
							units. </FONT></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">Following
							that, we prepared serial dilutions of monodisperse silica
							microspheres and obtained standard particle curve (<B>Fig.
							1</B>) which allows to
							convert Abs<SUB>600</SUB> measurements to
							an estimated number of cells. </FONT></P><P style="margin-bottom: 0in; line-height: 200%"><CENTER><B>	Figure
							1.</B> Standard particle curve obtained by using microspheres that
							are similar size to a cell displayed in (<B>A</B>) a linear scale and
							(<B>B</B>) a log scale.	</CENTER></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">The
							final calibration was that of fluorescein concentration. We generated
							a standard curve of fluorescence for fluorescein concentration by,
							again, making serial dilutions of fluorescein (<B>Fig.
							2</B>). This way we
							could convert our cell based readings of fluorescence to an
							equivalent fluorescein concentration.  The measurements were taken
							with the same setting as those which would be used measuring cell
							fluorescence. </FONT></P><P style="line-height: 200%"><CENTER><B>	Figure 2.</B>
							Fluorescein standard curve obtained by serial dilutions in (<B>A</B>)
							the linear scale and in (<B>B</B>) the log scale.	</CENTER></P><DIV class="fancy-title title-border-color"><H4>2. Cell measurement protocol</H4></DIV><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">We
							were provided with six different devices (Test device 1 -
							</FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364000"><FONT size="3" style="font-size: 12pt">BBa_J364000</FONT></A></FONT><FONT size="3" style="font-size: 12pt">,
							Test device 2 - </FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364001"><FONT size="3" style="font-size: 12pt">BBa_J364001</FONT></A></FONT><FONT size="3" style="font-size: 12pt">,
							Test device 3 - </FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364002"><FONT size="3" style="font-size: 12pt">BBa_J364002</FONT></A></FONT><FONT size="3" style="font-size: 12pt">,
							Test device 4 - </FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364007"><FONT size="3" style="font-size: 12pt">BBa_J364007</FONT></A></FONT><FONT size="3" style="font-size: 12pt">,
							Test device 5 - </FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364008"><FONT size="3" style="font-size: 12pt">BBa_J364008</FONT></A></FONT><FONT size="3" style="font-size: 12pt">,
							Test device 6 - </FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_J364009"><FONT size="3" style="font-size: 12pt">BBa_J364009</FONT></A></FONT><FONT size="3" style="font-size: 12pt">)</FONT><FONT size="3" style="font-size: 12pt">
							along with negative (</FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_R0040"><FONT size="3" style="font-size: 12pt">BBa_R0040</FONT></A></FONT><FONT size="3" style="font-size: 12pt">)
							</FONT><FONT size="3" style="font-size: 12pt">and positive
							(</FONT><FONT color="#0000ff"><A href="http://parts.igem.org/Part:BBa_I20270"><FONT size="3" style="font-size: 12pt">BBa_I20270</FONT></A></FONT><FONT size="3" style="font-size: 12pt">)</FONT><FONT size="3" style="font-size: 12pt">
							controls which then we transformed into </FONT><FONT size="3" style="font-size: 12pt"><I>E.
							coli</I></FONT><FONT size="3" style="font-size: 12pt"> DH5</FONT><FONT size="3" style="font-size: 12pt">α</FONT><FONT size="3" style="font-size: 12pt">
							strain. Devices express GFP under Anderson promoters of different
							strength and are in the pSB1C3 backbone which carries resistance to
							chloramphenicol. </FONT></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">We
							made overnight cultures of two colonies of each transformation plate.
							The next day, the cultures were diluted to OD<SUB>600</SUB>=0.02
							and grown for 6 hours. The absorbance (600 nm) (<B>Fig. 3A</B>) and
							fluorescence (485/520, gain = 50) (<B>Fig. 3B</B>) of cultures were measured
							at 0 and 6 hours. </FONT></P><P style="margin-bottom: 0in; line-height: 200%"><CENTER><B>	Figure 3.</B>
							Average absorbance (<B>A</B>) and fluorescence (<B>B</B>) measurements of the 2 colonies and 4 replicates for each 
							sample, taken after 6 hours of growth.	</CENTER></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">The
							negative control demonstrates the highest absorbance which could be
							the result of the lowest metabolic load of all the devices, since it
							has no GFP expressed. On the other hand, devices 1, 4 and 5 show much
							slower bacteria growth even though the fluorescence of these devices
							is not the highest. Furthermore, device 1 demonstrates a really
							moderate absorbance and fluorescence increase after 6 hours
							suggesting that environmental factors could have impeded sample
							growth.</FONT></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">Next,
							the previous data (absorbance and fluorescence) was normalized to the
							comparable OD units (<B>Fig. 4A</B>) and then to particles (<B>Fig. 4B</B>) so that we could
							determine the mean expression level of GFP per cell. </SPAN></FONT></P><P style="margin-bottom: 0in; line-height: 200%"><CENTER><B>	Figure 4.</B>
							Normalization of fluorescence to the OD units (<B>A</B>) and MFEL per particle (<B>B</B>).	</CENTER></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">After
							6 hours all the devices (except the negative control) demonstrates a
							relatively decreased level of fluorescence. That could be explained
							by cells reaching a certain level of GFP expression after which the
							fluorescence stops increasing whereas absorption steadily goes up.</SPAN></FONT></P><DIV class="fancy-title title-border-color"><H4>3. Colony forming units (CFU) per 0.1 OD<SUB>600</SUB></H4></DIV><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">The
							second approach is to calibrate OD</SPAN></FONT><SUB><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">600</SPAN></FONT></SUB><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">
							to CFU which reflects the cell count in the sample. For this approach
							only negative and positive controls were used.  </SPAN></FONT></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">The
							overnight cultures of two colonies per control were diluted to
							OD</SPAN></FONT><SUB><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">600</SPAN></FONT></SUB><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">=0.1
							(three replications) and serial dilutions were made which then were
							spreaded on agar plates. The next morning the colonies were counted
							to find out the number of cells in the samples. </SPAN></FONT></P><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt"><SPAN lang="lt-LT">NC
							1.1 and PC 1.2 samples  has shown relatively high and low values
							respectively comparing to other samples which could indicate a
							systematic error in a serial dilution step. </SPAN></FONT></P><SECTION id="section-conclusions" class="page-section"><H2>Conclusions</H2><P align="justify" style="margin-bottom: 0in; line-height: 200%"><FONT size="3" style="font-size: 12pt">
						In this study cell fluorescence depends on the strength of the promotor under which GFP was expressed. However, all the cells with different devices demonstrated a reduced fluorescence per cell after 6 hours indicating a slowed down GFP production. </FONT></P></SECTION></SECTION></SECTION></DIV></DIV></DIV></DIV></SECTION></DIV></BODY></HTML>